GSTP1 and lobular neoplasia: A study on LN patients with GSTP1 rs1695 polymorphism observed that heterozygote genotype has a better percentage of disease remission (p = 0.03) (Hajdinak et al., 2020), whereas another study on the same SNPs showed that rs1695 has a synergetic influence on CYC failure (Kumaraswami et al., 2017).